NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook

SAN DIEGO, CA--(Marketwired - January 09, 2017) - NuVasive, Inc. (NASDAQ: NUVA)

• Preliminary full year 2016 revenue of approximately $956 million; reflects 17.9% growth versus prior year, or 17.6% on a constant currency basis
• Preliminary full year 2016 non-GAAP operating profit margin expected to be in line with guidance of 16.0%
• Company expects full year 2017 revenue of $1.065 billion, which includes approximately $10 million in year-over-year currency headwinds, and non-GAAP operating profit margin expansion of approximately 100 basis points versus full year 2016

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today provided a financial performance update, including the announcement of select preliminary unaudited financial results for the full year ended December 31, 2016 and select financial performance guidance for the full year 2017.

"We are pleased to deliver stronger than expected preliminary results for 2016, demonstrating strength across all geographies, and are excited about our outlook for 2017," said Gregory T. Lucier, chairman and chief executive officer of NuVasive. "We remain committed to our longer-term financial performance goals and strategic initiatives that are expected to drive the Company's revenue growth and operating margin expansion targets, while continuing to transform healthcare with game-changing technologies."

Full Year 2016 Preliminary Results

NuVasive anticipates full year 2016 revenue will be approximately $956 million, reflecting 17.9% year-over-year growth, or 17.6% on a constant currency basis. Full year 2016 pro forma revenue, assuming acquisitions are included in the Company's financial results for the entire fiscal year, is expected to grow 8.7% on a constant currency basis. NuVasive anticipates preliminary fourth quarter 2016 revenue performance of approximately $265 million. Additionally, the Company expects full year 2016 non-GAAP operating profit margin will be in line with previous guidance of 16.0%.